Table 2.
Comparison of salivary parameters between the iNS and control participants
| Studied groups | iNS | Control n = 47 | ||
|---|---|---|---|---|
| Remission n = 26 | Relapse n = 21 | Total n = 47 | ||
| Salivary parameters | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD |
| Flow rate (ml/min) | 0.41 ± 0.26 | 0.48 ± 0.30 | 0.44 ± 0.27 | 0.46 ± 0.19 |
| pH | 7.27 ± 0.71 | 7.28 ± 0.70 | 7.28 ± 0.70 | 7.50 ± 0.50 |
| Buffer capacity (mmol/L) | 6.67 ± 5.83 | 4.95 ± 2.87 | 5.90 ± 4.78 | 4.56 ± 2.45 |
| Total protein (mg/ml) | 1.09 ± 0.62 | 1.24 ± 0.47 | 1.16 ± 0.56 | 1.00 ± 0.47 |
| α-amylase (J/ml) | 114.7 ± 135.1 | 95.4 ± 36.6 | 106.10 ± 103.00 | 113.36 ± 82.00 |
| Peroxidase (mIU/ml) | 0.45 ± 0.50e | 0.66 ± 0.44e,g | 0.54 ± 0.48 | 0.46 ± 0.31 g |
| Calcium (mg/dL) | 3.27 ± 1.52 | 2.93 ± 1.7 | 3.12 ± 1.45 | 3.38 ± 2.15 |
| Magnesium (mg/dL) | 0.50 ± 0.38f | 0.31 ± 0.26f,h | 0.41 ± 0.34a | 0.60 ± 0.38a,h |
| Inorganic phosphate (mg/dL) | 10.34 ± 3.68 | 11.71 ± 3.50 | 10.95 ± 3.63 | 10.33 ± 3.86 |
| Fluoride (ppm) | 0.15 ± 0.11i | 0.15 ± 0.09 k | 0.15 ± 0.10b | 0.21 ± 0.10b,i,k |
| Urea (mg/dL) | 33.57 ± 16.36 l | 37.18 ± 14.64 m | 35.19 ± 15.55c | 25.21 ± 10.78c,l,m, |
| Uric acid (mg/dL) | 2.64 ± 1.09n | 3.24 ± 1.34o | 2.90 ± 1.23d | 2.34 ± 1.04d,n,o |
iNS Idiopathic nephrotic syndrome
Significant difference at P < 0.05 between a–a, d–d, f–f, g–g, n–n and o–o
Significant difference at P < 0.01 between b–b, c–c, e–e, h–h, i–i, k–k, l–l and m–m